Laura Chambers

2.2k total citations · 1 hit paper
95 papers, 1.4k citations indexed

About

Laura Chambers is a scholar working on Surgery, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Laura Chambers has authored 95 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 38 papers in Reproductive Medicine and 31 papers in Obstetrics and Gynecology. Recurrent topics in Laura Chambers's work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (21 papers) and Intraperitoneal and Appendiceal Malignancies (20 papers). Laura Chambers is often cited by papers focused on Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (21 papers) and Intraperitoneal and Appendiceal Malignancies (20 papers). Laura Chambers collaborates with scholars based in United States, Canada and United Kingdom. Laura Chambers's co-authors include Chad M. Michener, J.W. Lenz, Vanessa Leone, Dionysios A. Antonopoulos, Joseph D. Dougherty, A. Glawe, Mae J. Ciancio, Kathy J. LePard, Eugene B. Chang and Jeff Kwak and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Public Health.

In The Last Decade

Laura Chambers

85 papers receiving 1.4k citations

Hit Papers

Exercise Prevents Weight Gain and Alters the Gut Microbio... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Chambers United States 17 444 375 325 235 221 95 1.4k
Rosiane Mattar Brazil 27 273 0.6× 248 0.7× 102 0.3× 1.4k 6.0× 225 1.0× 189 2.8k
R. B. Ness United States 22 182 0.4× 143 0.4× 168 0.5× 621 2.6× 582 2.6× 39 2.0k
Eliana Wendland Brazil 21 109 0.2× 437 1.2× 208 0.6× 691 2.9× 22 0.1× 76 1.7k
Rønnaug Ødegård Norway 17 233 0.5× 72 0.2× 224 0.7× 663 2.8× 124 0.6× 42 1.6k
on United Kingdom 5 116 0.3× 155 0.4× 180 0.6× 77 0.3× 30 0.1× 15 1.3k
Leslie Miller United States 23 180 0.4× 248 0.7× 143 0.4× 227 1.0× 381 1.7× 59 2.4k
Antti Saari Finland 15 205 0.5× 152 0.4× 216 0.7× 177 0.8× 65 0.3× 38 1.3k
Mehmet Vural Türkiye 18 78 0.2× 109 0.3× 52 0.2× 252 1.1× 120 0.5× 122 1.1k
Chiara Mameli Italy 18 156 0.4× 191 0.5× 149 0.5× 28 0.1× 33 0.1× 74 1.3k
Massimo Agosti Italy 28 209 0.5× 404 1.1× 230 0.7× 409 1.7× 49 0.2× 149 2.7k

Countries citing papers authored by Laura Chambers

Since Specialization
Citations

This map shows the geographic impact of Laura Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Chambers more than expected).

Fields of papers citing papers by Laura Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Chambers. The network helps show where Laura Chambers may publish in the future.

Co-authorship network of co-authors of Laura Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Chambers. A scholar is included among the top collaborators of Laura Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Chambers. Laura Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldstein, Naomi E., et al.. (2025). The Role of the Microbiome in Cancer Therapies. Hematology/Oncology Clinics of North America. 39(2). 269–294.
2.
Backes, Floor, et al.. (2025). Hyperthermic Intraperitoneal Chemotherapy in the Management of Ovarian, Fallopian Tube and Peritoneal Carcinomas. Surgical Oncology Clinics of North America. 34(2). 265–285. 1 indexed citations
3.
Chambers, Laura, et al.. (2024). From poo to promise: Fecal microbiota transplants support immunotherapy re-sensitization in solid tumors. Cell Host & Microbe. 32(8). 1217–1218. 4 indexed citations
4.
Lampert, Erika J., et al.. (2024). Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients. International Journal of Gynecological Cancer. 34(8). 1246–1252.
5.
Müller, Carolin, et al.. (2024). Feasibility and safety of hyperthermic intra-peritoneal chemotherapy in patients with ovarian cancer and chronic kidney disease. International Journal of Gynecological Cancer. 35(1). 100010–100010.
6.
Felix, Ashley S., Jennifer A. Sinnott, Bette J. Caan, et al.. (2024). Changes in anthropometry, adiposity, and inflammation in Black and White women engaged in intentional weight loss. Obesity. 32(12). 2398–2409. 1 indexed citations
7.
Fulton, Jessica, et al.. (2024). Evidence and best practices for trauma-informed care in gynecologic oncology patients. International Journal of Gynecological Cancer. 34(7). 1077–1088. 4 indexed citations
8.
Fulton, Jessica, et al.. (2024). Diagnosis and management of gastric-type endocervical adenocarcinoma: A case report and review of the literature. Gynecologic Oncology. 185. 165–172. 1 indexed citations
9.
Lampert, Erika J., Peter G. Rose, Robert Debernardo, et al.. (2023). Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer. Obstetrical & Gynecological Survey. 78(11). 648–649.
11.
Goel, Nidhi, et al.. (2023). Gastritis as an immunotherapy-related toxicity in the treatment of endometrial cancer: A case report. Gynecologic Oncology Reports. 47. 101174–101174. 1 indexed citations
12.
Cosgrove, Casey, et al.. (2023). Evaluation of Efficacy and Adverse Events After Second Immunotherapy Exposure in Endometrial and Cervical Carcinoma. Obstetrics and Gynecology. 142(2). 360–363. 3 indexed citations
13.
Yao, Meng, Michelle Kuznicki, Roberto Vargas, et al.. (2022). Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer. Gynecologic Oncology. 165(1). 90–96. 7 indexed citations
14.
Chambers, Laura, Meng Yao, Anna Chichura, et al.. (2021). Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer. Gynecologic Oncology. 162(3). 645–651. 11 indexed citations
16.
Chambers, Laura, Michelle Kuznicki, Max Horowitz, et al.. (2020). A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology. Gynecologic Oncology. 158(3). 794–802. 25 indexed citations
17.
Kuznicki, Michelle, et al.. (2020). Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature. Journal of Minimally Invasive Gynecology. 28(3). 513–526.e1. 28 indexed citations
18.
Mahdi, Haider, Xiaozhen Han, Laura Chambers, & Roberto Vargas. (2017). Trends in Survival of Patients With Uterine Serous Carcinoma From 1988 to 2011. International Journal of Gynecological Cancer. 27(6). 1155–1164. 6 indexed citations
19.
Evans, Christian C., Kathy J. LePard, Jeff Kwak, et al.. (2014). Exercise Prevents Weight Gain and Alters the Gut Microbiota in a Mouse Model of High Fat Diet-Induced Obesity. PLoS ONE. 9(3). e92193–e92193. 468 indexed citations breakdown →
20.
Linden, Wolfgang von der, et al.. (1993). Sex differences in social support, self-deception, hostility, and ambulatory cardiovascular activity.. Health Psychology. 12(5). 376–380. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026